Stanford Accelerated Recovery Trial (START)

NCT01067144 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

422

Enrollment

OTHER

Sponsor class

Stopped Trial met futility stopping point

Conditions

Pain
Breast Cancer
Lung Cancer

Interventions

DRUG: Gabapentin
DRUG: Lorazepam (active control)
DRUG: Placebo (inactive)

Sponsor

Stanford University